Chemoinformaics analysis of cis-3-Hexenyl phenylacetate
| Molecular Weight | 218.296 | nRot | 6 |
| Heavy Atom Molecular Weight | 200.152 | nRig | 8 |
| Exact Molecular Weight | 218.131 | nRing | 1 |
| Solubility: LogS | -4.035 | nHRing | 0 |
| Solubility: LogP | 3.699 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 34 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 16 | No. of Aromatic Carbocycles | 1 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 18 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 14 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 6 |
| nHA | 2 | APOL | 36.9863 |
| nHD | 0 | BPOL | 20.6617 |
| QED | 0.416 |
| Synth | 1.974 |
| Natural Product Likeliness | 0.519 |
| NR-PPAR-gamma | 0.826 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0 |
| Pgp-sub | 0.005 |
| HIA | 0.003 |
| CACO-2 | -4.311 |
| MDCK | 0.0000445 |
| BBB | 0.732 |
| PPB | 0.947756 |
| VDSS | 2.218 |
| FU | 0.0655529 |
| CYP1A2-inh | 0.976 |
| CYP1A2-sub | 0.129 |
| CYP2c19-inh | 0.951 |
| CYP2c19-sub | 0.116 |
| CYP2c9-inh | 0.747 |
| CYP2c9-sub | 0.653 |
| CYP2d6-inh | 0.045 |
| CYP2d6-sub | 0.145 |
| CYP3a4-inh | 0.504 |
| CYP3a4-sub | 0.3 |
| CL | 14.944 |
| T12 | 0.813 |
| hERG | 0.06 |
| Ames | 0.079 |
| ROA | 0.066 |
| SkinSen | 0.919 |
| Carcinogencity | 0.585 |
| EI | 0.974 |
| Respiratory | 0.065 |
| NR-Aromatase | 0.015 |
| Antiviral | Yes |
| Prediction | 0.62354 |